December 22, 2022 01:07 PM ESTUpdated January 12, 01:28 PM

Startup making software for pharma manufacturing industry nets $12M+ Series A

Tyler Patchen

News Reporter

Ganymede Bio CEO and co-founder Nathan Clark claims software for biotechs is 10 to 20 years behind other industries. His company just received $12.75 million …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Startup making software for pharma manufacturing industry nets $12M+ Series A

Tyler Patchen

News Reporter

Sign up to read this article for free.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

BridgeBio shares promising results in trial of Canavan disease gene therapy

CRISPR therapy reduces swelling attacks by 81% in Intellia follow-up study

Facing lost rebates, MGM Resorts to stop covering GLP-1 weight loss shots

Exclusive: University of Toronto spinout raises $53.5M to create new obesity drugs with AI

Icon's quarterly earnings hit by biotech and pharma pullback

IDEAYA Biosciences: Targeting unmet market needs with precision oncology

Start­up mak­ing soft­ware for phar­ma man­u­fac­tur­ing in­dus­try nets $12M+ Se­ries A

News Reporter

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

Startup making software for pharma manufacturing industry nets $12M+ Series A